ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model.
Y Al Ojaimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.